Tech Center 1600 • Art Units: 1611
This examiner grants 43% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17421747 | LTA4H INHIBITORS FOR THE TREATMENT OF HIDRADENITIS SUPPURATIVA | Final Rejection | NOVARTIS AG |
| 17418091 | PHARMACEUTICAL PREPARATION | Final Rejection | KOWA COMPANY, LTD. |
| 18098014 | Optimized Topical Formulation for Lidocaine Pain Relief Gel | Non-Final OA | Focus Consumer Healthcare, LLC |
| 17650594 | NANOPARTICLE ISOFLAVONE COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | Final Rejection | Humanetics Corporation |
| 17618020 | MICRONIZED DRUG RESINATE-BASED PHARMACEUTICAL COMPOSITIONS AND METHODS OF PREPARATION THEREOF | Final Rejection | Brillian Pharma Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy